Rigel Pharmaceuticals, Inc. (RIGL)
25.95
-0.65
(-2.44%)
USD |
NASDAQ |
Mar 13, 16:00
25.92
-0.03
(-0.12%)
After-Hours: 20:00
Rigel Pharmaceuticals Total Assets (Quarterly) : 560.62M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| Nektar Therapeutics | 280.41M |
| Ironwood Pharmaceuticals, Inc. | 396.90M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Amicus Therapeutics, Inc. | 949.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 169.14M |
| Shareholders Equity (Quarterly) | 391.48M |
| Debt to Equity Ratio | 0.1362 |
| Current Ratio | 2.420 |
| Net Debt Paydown Yield | 0.18% |